Quick Search Issue Search Advanced Search
Clinical Study on ~(131)I Ablation for Residual Normal Thyroid Tissue in Postoperative Thyroid Cancer Patients[J]. Journal of Isotopes, 2003, 16(Z1): 245-245. DOI: 10.7538/tws.2003.16.Z1.0245
Citation: Clinical Study on ~(131)I Ablation for Residual Normal Thyroid Tissue in Postoperative Thyroid Cancer Patients[J]. Journal of Isotopes, 2003, 16(Z1): 245-245. DOI: 10.7538/tws.2003.16.Z1.0245
shu

Clinical Study on ~(131)I Ablation for Residual Normal Thyroid Tissue in Postoperative Thyroid Cancer Patients

    Graphical Abstract
    • Abstract
  • 115 patients of postoperative thyroid cancer are treated with 131I to ablate for residual normal thyroid tissue. 2 960~3 700 MBq (80~100 mCi) 131I ablative dose is administrated. 80-120 mg thyroid extract is given for 3 months, then stopped. 50μg T3 daily is given for 15 days and stopped for over 15 days. The 131I whole-body scan are performed. The effective rate of 131I ablation is 70%.
    • FullText(HTML)
  • loading
    • References (13)
    • Related Articles
  • Supplements (0)

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return